ESR2 and neoplasm: The loss of ERβ expression correlates with increased proliferation in the ERβ-knock out/TRAMP (transgenic adenocarcinoma of mouse prostate) mouse model [10] as well as in human prostate cancer tumor tissue [11, 12].